Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-25 @ 4:42 AM
NCT ID:
NCT04864418
Eligibility Criteria:
Inclusion Criteria:
* has recurrent or metastatic solid cancer that has been proven histologically or cytologically and cannot be treated with surgery or radiotherapy for the purpos of complete remission
* does not have a standard treatment that can be applied clinically according to the investigator's judgment
* has an expected life expectancy of more than 3 months
* adults aged 19 or older based on screening day
* ECOG performance status : 0\~1
Exclusion Criteria:
* Has a history of hypersensitivity or other contraindications to rhGM-CSF and Montanide ISA 51 VG
* Has a history of other primary malignant tumor
* Has autoimmune diseases or inflammatory diseases
* Has a history of active primary immunodeficiency disease
* Has active infection including tuberculosis, hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection
* Is pregnant or breastfeeding or expecting to conceive children
* has a history of immune suppression therapy ≤4 weeks prior to the screening day
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT04864418
Study Brief:
Protocol Section:
NCT04864418